Abstract: A method for desalinating and recycling the brine exiting a salt cavern. This method reduces the overall make-up water demand to wash a salt cavern, eliminates the brine disposal well and controls the cavern growth rate during disposal operations. The method includes the steps of: a) desalinating brine emerging from the salt cavern, and creating a stream of saline water, a stream of non-saline water and a stream of salt; b) recycling the stream volumes and combining the stream of non-saline and saline water with make-up water, thereby reducing demand for make-up water, c) pumping the salinated water into the salt cavern, and controlling the rate of growth of the salt cavern while disposing of wastes in the cavern, and repeating steps a) and b) substituting the make-up water with a waste mixture.

Abstract: A method for desalinating and recycling the brine exiting a salt cavern. This method reduces the overall make-up water demand to wash a salt cavern, eliminates the brine disposal well and controls the cavern growth rate during disposal operations. The method includes the steps of: a) desalinating brine emerging from the salt cavern, and creating a stream of saline water, a stream of non-saline water and a stream of salt; b) recycling the stream volumes and combining the stream of non-saline and saline water with make-up water, thereby reducing demand for make-up water, c) pumping the salinated water into the salt cavern, and controlling the rate of growth of the salt cavern while disposing of wastes in the cavern, and repeating steps a) and b) substituting the make-up water with a waste mixture.

Abstract: The present invention provides a method comprising administering to a patient suffering from an endocrine disorder characterized by partial endogenous growth hormone activity or signaling an amount of insulin-like growth factor-1 (IGF-1) and an amount of growth hormone (GH) that in combination are effective to improve growth or metabolism in the patient, where the patient receives IGF-1 in a single daily administration and receives GH in a single daily administration, and where the single administrations are administered to the patient substantially contemporaneously each day.

Abstract: The present invention provides a method comprising administering to a patient suffering from an endocrine disorder characterized by partial endogenous growth hormone activity or signaling an amount of insulin-like growth factor-1 (IGF-1) and an amount of growth hormone (GH) that in combination are effective to improve growth or metabolism in the patient, where the patient receives IGF-1 in a single daily administration and receives GH in a single daily administration, and where the single administrations are administered to the patient substantially contemporaneously each day.

Abstract: The present invention provides methods and compositions for increasing the growth rates, alleviating the symptoms, or improving the metabolism of human patients having an endocrine disorder characterized by partial endogenous growth hormone activity or signaling. The invention provides a method comprising administering to a patient suffering from an endocrine disorder characterized by partial endogenous growth hormone activity or signaling an amount of insulin-like growth factor-1 (IGF-1) effective to improve metabolism in the patient, where the patient receives IGF-1 in a single daily administration.

Abstract: The present invention provides standard deviation score (SDS) calculators, which SDS calculators are useful for transforming insulin-like growth factor-1 (IGF-1) concentrations to IGF-1 standard deviation scores. In one embodiment, IGF-1 blood levels are calculated so as to take into account IGFBP-3 blood levels (and, optionally, IGF-2 blood levels) to provide an IGF-1 production rate, which can be used to calculate an IGF-1 production rate SDS. The IGF-1 SDS and IGF-1 production rate SDS are particularly useful in assessing the stimulated rate of IGF-1 production in response to, for example, growth hormone therapy.

Abstract: The present invention provides methods and compositions for increasing the growth rates, alleviating the symptoms, or improving the metabolism of human patients having an endocrine disorder characterized by partial endogenous growth hormone activity or signaling. The invention provides a method comprising administering to a patient suffering from an endocrine disorder characterized by partial endogenous growth hormone activity or signaling an amount of insulin-like growth factor-1 (IGF-1) effective to improve metabolism in the patient, where the patient receives IGF-1 in a single daily administration.

Abstract: Transformed The Mind Jewellery is a unique and powerful tool for healing. The basic understanding of this unit that it uses multiple stimulus to provide touch healing through pulses and vibration, a phototherapeutic lighting system that interacts with the skin and of the being on the cellular level and beyond a sub-audible, subliminal message transferred through a speaker. This said message is the main program that allows the control of pulse light and sound to simultaneously stimulate the being of the wearer of this Jewellery. This unit draws in its information and overnight charge through a USB2.0 system. This charge is stored in the lithium ion batteries. A charge is transferred throughout the system. The Jewellery has a high draw for its small size, thus a placement of five lithium ion rechargeable batteries have been placed in the Jewellery piece.